Friday November 27 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Karmanos Cancer Institute

When cancer strikes, your first chance is your best chance. And your best chance is at the Barbara Ann Karmanos Cancer Institute. Backed by state-of-the-science cancer research conducted right here in Detroit, the Institute is the only cancer center in southeast Michigan where teams of cancer experts diagnose patients with world-class precision and compassionate care.We work with hundreds of doctors statewide to arrange for care convenient for patients and families. Together, our cancer teams and your doctor can recommend the best treatment options with the Institute’s immediate access to the latest cancer-fighting drugs and therapies


Contact Details:
4100 John R
Detroit
Michigan
48201
United States of America
Tel:(1-800-527-6266)
Fax:
Email:info@karmanos.org
WWW:

www.karmanos.org/




Loading...

Recent Publications by Karmanos Cancer Institute:

Fibroblast Hepatocyte Growth Factor Promotes Invasion of Human Mammary Ductal Carcinoma In situ.
Stromal-derived hepatocyte growth factor (HGF) acting through its specific...
19th November, 2009
Department of Pharmacology and Karmanos Cancer Institute, Wayne State Cancer Res. 2009 Nov 17.
DOI Direct Link
The transcription activation domain of Rpn4 is separate from its degrons.
The proteasome homeostasis in Saccharomyces cerevisiae is regulated by a...
17th November, 2009
Barbara Ann Karmanos Cancer Institute, Wayne State University School of Int J Biochem Cell Biol. 2009 Nov 12.
DOI Direct Link
Inhibition of tumor proteasome activity by gold-dithiocarbamato complexes via both redox-dependent and -independent processes.
We have previously reported on a gold(III) complex, namely [AuBr(2)(DMDT)]...
17th November, 2009
The Prevention Program, Department of Pathology, Barbara Ann Karmanos J Cell Biochem. 2009 Nov 12.
DOI Direct Link
Satraplatin: leading the new generation of oral platinum agents.
BACKGROUND: In recent years, JM-216/satraplatin (GPC Biotech, Inc.) has...
6th November, 2009
Department of Medicine, Division of Hematology/Oncology, Wayne State Expert Opin Investig Drugs. 2009 Nov;18(11):1787-97.
DOI Direct Link
Resistance to epidermal growth factor receptor tyrosine kinase inhibitors.
BACKGROUND: In recent years, JM-216/satraplatin (GPC Biotech, Inc.) has...
5th November, 2009
Karmanos Cancer Institute, Wayne State University, Detroit, Michigan J Thorac Oncol. 2009 Nov;4(11 Suppl 3):S1084-5.
DOI Direct Link

View more Karmanos Cancer Institute research publications.

Press Releases on Karmanos Cancer Institute:

BioPortfolio Logo
Sky Foundation, Inc. Raises More Than $100,000 to Find a Test for Early Detection of Pancreatic Cancer 24th November, 2009 Sky Foundation, Inc.
BLOOMFIELD HILLS, Mich., Nov. 24 /PRNewswire/ -- Sky Foundation, Inc., a non-profit foundation dedicated to raising $500,000 to fund research to develop a blood test for the early detection of
Karmanos Cancer Institute Launches Company and Innovative Breast Imaging Tool 16th November, 2009 Karmanos Cancer Institute
DETROIT, Nov. 16 /PRNewswire-USNewswire/ -- After more than 10 years of research and development, the Barbara Ann Karmanos Cancer Institute announced its launch of a new company to build and market a
Karmanos Cancer Center Most Preferred Hospital for Cancer Care in Southeast Michigan, Third Consecutive Year 9th November, 2009 Karmanos Cancer Institute
DETROIT, Nov. 9 /PRNewswire-USNewswire/ -- For the third consecutive year, the Barbara Ann Karmanos Cancer Center has been selected the most preferred hospital for cancer care in southeast Michigan,
Karmanos Cancer Institute to Launch Health Initiative Focused on Environmentally-Associated Cancers 21st October, 2009 Barbara Ann Karmanos Cancer Institute
DETROIT, Oct. 21 /PRNewswire-USNewswire/ -- The Barbara Ann Karmanos Cancer Institute, in cooperation with Blue Cross Blue Shield of Michigan (BCBSM), will launch a targeted health initiative in
Karmanos Cancer Institute Immunology Researcher Obtains Nearly $1 Million National Institutes of Health Grant 20th October, 2009 Barbara Ann Karmanos Cancer Institute
DETROIT, Oct. 20 /PRNewswire-USNewswire/ -- Venuprasad K. Poojary, Ph.D., assistant professor at the Barbara Ann Karmanos Cancer Institute and Wayne State University School of Medicine, has secured a

BioNews Results for Karmanos Cancer Institute:

Karmanos Cancer Institute spins off new company to build breast cancer screening device
Crains Detroit Business:  Nov 20 2009 7:14AM Matching: karmanos cancer institute
Exelixis Reports Encouraging Phase 1 Data For The PI3K Inhibitor Xl147 (SAR245408) In Combination With Erlotin
Medical News Today:  Nov 20 2009 7:16AM Matching: karmanos cancer institute
Medical News: Exelixis Reports Encouraging Phase 1 Data For The PI3K Inhibitor Xl147 (SAR245408) In Combination With Erlotinib At The AACR-NCI-EORTC Conference
BioFind:  Nov 20 2009 12:21PM Matching: karmanos cancer institute
Karmanos Cancer Institute spins off new company to build breast cancer screening device
Modern Healthcare:  Nov 20 2009 5:07AM Matching: karmanos cancer institute
Exelixis Reports Encouraging Phase 1 Data for the PI3K Inhibitor Xl147 (SAR245408) in Combination with Erlotin
Genetic Engineering News:  Nov 18 2009 6:41PM Matching: karmanos cancer institute
Promote your company here: BioNewsCast - Press Release Distribution

View more Karmanos Cancer Institute news.

Karmanos Cancer Institute Patents:

US Patent No.Title
7499745 Multidimensional bioelectrical tissue analyzer
5801002 Galactoside-binding-protein useful in the diagnosis and inhibition of of metastasis
5834442 Method for inhibiting cancer metastasis by oral administration of soluble modified citrus pectin
6385474 Method and apparatus for high-resolution detection and characterization of medical pathologies
6450960 Real-time three-dimensional acoustoelectronic imaging and characterization of objects

View more Karmanos Cancer Institute patents.

BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 302 individuals from Karmanos Cancer Institute using this service.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 386 times since April 2007, the link to the organisation's website has been followed 113 times

Recent Search Terms used to find this page: afp 464 in Karmanos | .

Search for more companies in Detroit

Search for more companies in Michigan



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Karmanos Cancer Institute

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.